ALT
Altimmune Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| 11-13-2018 | 08-14-2018 | 05-15-2018 | 03-28-2018 | 11-09-2017 after market close | 08-09-2017 | |
|---|---|---|---|---|---|---|
| Actual EPS | -1.73 | -0.16 | -0.23 | -0.12 | -0.34 | -0.26 |
| Consensus EPS | -3.6 | -0.15 | -0.5 | -0.5 | -0.23 | |
| Estimated EPS | -3.6 | -0.15 | -0.5 | -0.5 | -0.23 | |
| Number of Estimates | 1 | 1 | 1 | 1 | 1 | |
| EPS Surprise | $1.87 | -$0.01 | $0.27 | $0.38 | -$0.11 |
Stats
Summary
Altimmune Inc is a clinical stage immunotherapeutic biotechnology company. It has two vaccine delivery platforms, RespirVec and Densigen.
Market Cap: 28.8 Million
Primary Exchange: NASDAQ Global Market
Website: http://www.altimmune.com
Shares Outstanding: 15.7 Million
Float: 10.6 Million
Dividend: 0.0 (0.0%)
Beta: 2.444308
Sector: Healthcare
Industry: Biotechnology
Short Interest (Jan 12, 2018): 646 Thousand
Ethical Flags
Longest drawdown: 601 trading days
From: 2017-01-10 To: 2019-06-12
Lowest Point:
Altimmune appoints Will Brown as CFO.
via: SeekingAlpha at 2019-06-12 07:15:24:000
Altimmune ( ALT ) announced it has appointed Will Brown as Chief Financial Officer. More news on: Altimmune, Inc., Read more … read more...
Altimmune appoints Will Brown as CFO.
via: SeekingAlpha at 2019-06-12 07:15:24:000
Altimmune ( ALT ) announced it has appointed Will Brown as Chief Financial Officer. More news on: Altimmune, Inc., Read more … read more...
Altimmune -1.7% as chief medical officer resigns
via: SeekingAlpha at 2019-06-07 12:21:27:000
Dr. Sybil Tasker has resigned as chief medical officer of Altimmune (NASDAQ: ALT ), according to an SEC filing. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune -1.7% as chief medical officer resigns
via: SeekingAlpha at 2019-06-07 12:21:27:000
Dr. Sybil Tasker has resigned as chief medical officer of Altimmune (NASDAQ: ALT ), according to an SEC filing. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune -1.7% as chief medical officer resigns
via: SeekingAlpha at 2019-06-07 12:21:27:000
Dr. Sybil Tasker has resigned as chief medical officer of Altimmune (NASDAQ: ALT ), according to an SEC filing. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune -1.7% as chief medical officer resigns
via: SeekingAlpha at 2019-06-07 12:21:27:000
Dr. Sybil Tasker has resigned as chief medical officer of Altimmune (NASDAQ: ALT ), according to an SEC filing. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune -1.7% as chief medical officer resigns
via: SeekingAlpha at 2019-06-07 12:21:27:000
Dr. Sybil Tasker has resigned as chief medical officer of Altimmune (NASDAQ: ALT ), according to an SEC filing. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune, Inc. (ALT) CEO Vipin Garg on Q1 2019 Results - Earnings Call Transcript
via: SeekingAlpha at 2019-05-15 08:25:20:000
Altimmune, Inc. (ALT) Q1 2019 Earnings Conference Call May 15, 2019 08:30 AM ET Company Participants Vipin Garg - Chief Executive Officer Will Brown - Acting Chief Financial Officer Scot Roberts - Chief Scientific Officer Conference Call Participants Jerry Isaacson - ROTH C… read more...
Altimmune, Inc. (ALT) CEO Vipin Garg on Q1 2019 Results - Earnings Call Transcript
via: SeekingAlpha at 2019-05-15 08:25:20:000
Altimmune, Inc. (ALT) Q1 2019 Earnings Conference Call May 15, 2019 08:30 AM ET Company Participants Vipin Garg - Chief Executive Officer Will Brown - Acting Chief Financial Officer Scot Roberts - Chief Scientific Officer Conference Call Participants Jerry Isaacson - ROTH C… read more...
Altimmune, Inc. (ALT) CEO Vipin Garg on Q1 2019 Results - Earnings Call Transcript
via: SeekingAlpha at 2019-05-15 08:25:20:000
Altimmune, Inc. (ALT) Q1 2019 Earnings Conference Call May 15, 2019 08:30 AM ET Company Participants Vipin Garg - Chief Executive Officer Will Brown - Acting Chief Financial Officer Scot Roberts - Chief Scientific Officer Conference Call Participants Jerry Isaacson - ROTH C… read more...
Altimmune reports Q1 results
via: SeekingAlpha at 2019-05-14 12:44:14:000
Altimmune (NASDAQ: ALT ): Q1 GAAP EPS of -$0.27. Revenue of $2.95M (+9.3% Y/Y) Press Release More news on: Altimmune, Inc., Earnings news and commentary, Healthcare stocks news, , read more...
Altimmune Plans To Progress HepTcell But Market Shrugs It Off
via: SeekingAlpha at 2019-04-15 08:41:38:000
On April 12th, Altimmune ( ALT ) presented Phase I HepTcell data at the International Liver Congress in Vienna, Austria. Altimmune's immunotherapeutic synthetic peptide vaccine candidate demonstrated admirable safety and justified the company's plan to move into a Phase II study. Admittedly,… read more...
Altimmune Plans To Progress HepTcell But Market Shrugs It Off
via: SeekingAlpha at 2019-04-15 08:41:38:000
On April 12th, Altimmune ( ALT ) presented Phase I HepTcell data at the International Liver Congress in Vienna, Austria. Altimmune's immunotherapeutic synthetic peptide vaccine candidate demonstrated admirable safety and justified the company's plan to move into a Phase II study. Admittedly,… read more...
Altimmune Plans To Progress HepTcell But Market Shrugs It Off
via: SeekingAlpha at 2019-04-15 08:41:38:000
On April 12th, Altimmune ( ALT ) presented Phase I HepTcell data at the International Liver Congress in Vienna, Austria. Altimmune's immunotherapeutic synthetic peptide vaccine candidate demonstrated admirable safety and justified the company's plan to move into a Phase II study. Admittedly,… read more...
Healthcare stocks among major premarket losers
via: SeekingAlpha at 2019-04-05 05:16:12:000
AquaBounty Technologies (NASDAQ: AQB ) -23% on pricing stock offering. More news on: AquaBounty Technologies, Inc., Duluth Holdings Inc., Merrimack Pharmaceuticals, Inc., Stocks on the move, Read more … read more...
Healthcare stocks among major premarket losers
via: SeekingAlpha at 2019-04-05 05:16:12:000
AquaBounty Technologies (NASDAQ: AQB ) -23% on pricing stock offering. More news on: AquaBounty Technologies, Inc., Duluth Holdings Inc., Merrimack Pharmaceuticals, Inc., Stocks on the move, Read more … read more...
Healthcare stocks among major premarket losers
via: SeekingAlpha at 2019-04-05 05:16:12:000
AquaBounty Technologies (NASDAQ: AQB ) -23% on pricing stock offering. More news on: AquaBounty Technologies, Inc., Duluth Holdings Inc., Merrimack Pharmaceuticals, Inc., Stocks on the move, Read more … read more...
Healthcare stocks among major premarket losers
via: SeekingAlpha at 2019-04-05 05:16:12:000
AquaBounty Technologies (NASDAQ: AQB ) -23% on pricing stock offering. More news on: AquaBounty Technologies, Inc., Duluth Holdings Inc., Merrimack Pharmaceuticals, Inc., Stocks on the move, Read more … read more...
Healthcare stocks among major premarket losers
via: SeekingAlpha at 2019-04-05 05:16:12:000
AquaBounty Technologies (NASDAQ: AQB ) -23% on pricing stock offering. More news on: AquaBounty Technologies, Inc., Duluth Holdings Inc., Merrimack Pharmaceuticals, Inc., Stocks on the move, Read more … read more...
Key events next week - healthcare
via: SeekingAlpha at 2019-04-05 03:00:52:000
Noteworthy events during the week of April 7 - 13 for healthcare investors. More news on: Cigna Corporation, CVS Health Corporation, Humana Inc., Healthcare stocks news, , Read more … read more...
Key events next week - healthcare
via: SeekingAlpha at 2019-04-05 03:00:52:000
Noteworthy events during the week of April 7 - 13 for healthcare investors. More news on: Cigna Corporation, CVS Health Corporation, Humana Inc., Healthcare stocks news, , Read more … read more...
Key events next week - healthcare
via: SeekingAlpha at 2019-04-05 03:00:52:000
Noteworthy events during the week of April 7 - 13 for healthcare investors. More news on: Cigna Corporation, CVS Health Corporation, Humana Inc., Healthcare stocks news, , Read more … read more...
Key events next week - healthcare
via: SeekingAlpha at 2019-04-05 03:00:52:000
Noteworthy events during the week of April 7 - 13 for healthcare investors. More news on: Cigna Corporation, CVS Health Corporation, Humana Inc., Healthcare stocks news, , Read more … read more...
Key events next week - healthcare
via: SeekingAlpha at 2019-04-05 03:00:52:000
Noteworthy events during the week of April 7 - 13 for healthcare investors. More news on: Cigna Corporation, CVS Health Corporation, Humana Inc., Healthcare stocks news, , Read more … read more...
Altimmune, Inc. (ALT) CEO Vipin Garg on Q4 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2019-04-02 09:35:09:000
Altimmune, Inc. (ALT) Q4 2018 Earnings Conference Call April 02, 2019 08:30 AM ET Company Participants Paul Arndt - LifeSci Advisors Vipin Garg - Chief Executive Officer Will Brown - Acting Chief Financial Officer Scot Roberts - Chief Scientific Officer Conference Call … read more...
Altimmune, Inc. (ALT) CEO Vipin Garg on Q4 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2019-04-02 09:35:09:000
Altimmune, Inc. (ALT) Q4 2018 Earnings Conference Call April 02, 2019 08:30 AM ET Company Participants Paul Arndt - LifeSci Advisors Vipin Garg - Chief Executive Officer Will Brown - Acting Chief Financial Officer Scot Roberts - Chief Scientific Officer Conference Call … read more...
Altimmune, Inc. (ALT) CEO Vipin Garg on Q4 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2019-04-02 09:35:09:000
Altimmune, Inc. (ALT) Q4 2018 Earnings Conference Call April 02, 2019 08:30 AM ET Company Participants Paul Arndt - LifeSci Advisors Vipin Garg - Chief Executive Officer Will Brown - Acting Chief Financial Officer Scot Roberts - Chief Scientific Officer Conference Call … read more...
WBA, EVOK and UGI among premarket losers
via: SeekingAlpha at 2019-04-02 05:17:46:000
Energy Focus (NASDAQ: EFOI ) -52% on Q4 earnings . More news on: Energy Focus, Inc., Evoke Pharma, Inc., Apyx Medical Corporation, Stocks on the move, Read more … read more...
WBA, EVOK and UGI among premarket losers
via: SeekingAlpha at 2019-04-02 05:17:46:000
Energy Focus (NASDAQ: EFOI ) -52% on Q4 earnings . More news on: Energy Focus, Inc., Evoke Pharma, Inc., Apyx Medical Corporation, Stocks on the move, Read more … read more...
WBA, EVOK and UGI among premarket losers
via: SeekingAlpha at 2019-04-02 05:17:46:000
Energy Focus (NASDAQ: EFOI ) -52% on Q4 earnings . More news on: Energy Focus, Inc., Evoke Pharma, Inc., Apyx Medical Corporation, Stocks on the move, Read more … read more...
Altimmune reports FY results
via: SeekingAlpha at 2019-04-01 12:28:02:000
Altimmune (NASDAQ: ALT ): FY GAAP EPS of -$15.16. More news on: Altimmune, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Altimmune Reports Positive NasoVax Data And Is Looking For Partners
via: SeekingAlpha at 2019-03-26 04:41:33:000
Altimmune ( ALT ) recently announced additional positive data from their NasoVAX Phase II extension study that claimed that 100% of the reported subjects remained seroprotected over a year after vaccination. In addition, their seroconversion rate was unaffected beyond one year after vaccinat… read more...
Altimmune Reports Positive NasoVax Data And Is Looking For Partners
via: SeekingAlpha at 2019-03-26 04:41:33:000
Altimmune ( ALT ) recently announced additional positive data from their NasoVAX Phase II extension study that claimed that 100% of the reported subjects remained seroprotected over a year after vaccination. In addition, their seroconversion rate was unaffected beyond one year after vaccinat… read more...
Altimmune Reports Positive NasoVax Data And Is Looking For Partners
via: SeekingAlpha at 2019-03-26 04:41:33:000
Altimmune ( ALT ) recently announced additional positive data from their NasoVAX Phase II extension study that claimed that 100% of the reported subjects remained seroprotected over a year after vaccination. In addition, their seroconversion rate was unaffected beyond one year after vaccinat… read more...
FDX and TME among premarket losers
via: SeekingAlpha at 2019-03-20 05:12:39:000
Soleno Therapeutics (NASDAQ: SLNO ) -10% . More news on: Soleno Therapeutics, Inc., Tencent Music Entertainment Group, Cellectar Biosciences, Inc., Stocks on the move, Read more … read more...
FDX and TME among premarket losers
via: SeekingAlpha at 2019-03-20 05:12:39:000
Soleno Therapeutics (NASDAQ: SLNO ) -10% . More news on: Soleno Therapeutics, Inc., Tencent Music Entertainment Group, Cellectar Biosciences, Inc., Stocks on the move, Read more … read more...
FDX and TME among premarket losers
via: SeekingAlpha at 2019-03-20 05:12:39:000
Soleno Therapeutics (NASDAQ: SLNO ) -10% . More news on: Soleno Therapeutics, Inc., Tencent Music Entertainment Group, Cellectar Biosciences, Inc., Stocks on the move, Read more … read more...
Healthcare dominate midday movers
via: SeekingAlpha at 2019-03-19 08:43:48:000
Gainers: Vaxart (NASDAQ: VXRT ) +108% . Sorrento Therapeutics (NASDAQ: SRNE ) +34% . Conformis (NASDAQ: CFMS ) +23% . Blucora (NASDAQ: BCOR ) +20% . StoneCo (NASDAQ: STNE ) +19% . Realm Therapeutics ( RLM ) +19% . Iterum Therapeutics (NASDAQ: ITRM ) +18% . Altimmune (NASDAQ: A… read more...
SDRL, SBGL and CRBP among premarket gainers
via: SeekingAlpha at 2019-03-19 05:13:15:000
Altimmune (NASDAQ: ALT ) +44% on positive NasoVAX data . More news on: Altimmune, Inc., Vaxart, Inc., Cellectar Biosciences, Inc., Stocks on the move, Read more … read more...
Altimmune up 37% premarket on positive NasoVAX data
via: SeekingAlpha at 2019-03-19 04:00:44:000
Nano cap Altimmune (NASDAQ: ALT ) is up 37% premarket on robust volume in response to new data from a Phase 2 extension study of intranasal flu vaccine candidate NasoVAX. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Microcaps mostly among midday movers
via: SeekingAlpha at 2019-03-08 07:57:19:000
Gainers: TrovaGene (NASDAQ: TROV ) +74% . Stellar Biotechnologies (NASDAQ: SBOT ) +51% . Tenax Therapeutics (NASDAQ: TENX ) +51% . Globus Maritime (NASDAQ: GLBS ) +47% . Seelos Therapeutics (NASDAQ: SEEL ) +36% . Tonix Pharmaceuticals Holding (NASDAQ: TNXP ) +28% . Pulmatrix (N… read more...
Microcaps mostly among midday movers
via: SeekingAlpha at 2019-03-08 07:57:19:000
Gainers: TrovaGene (NASDAQ: TROV ) +74% . Stellar Biotechnologies (NASDAQ: SBOT ) +51% . Tenax Therapeutics (NASDAQ: TENX ) +51% . Globus Maritime (NASDAQ: GLBS ) +47% . Seelos Therapeutics (NASDAQ: SEEL ) +36% . Tonix Pharmaceuticals Holding (NASDAQ: TNXP ) +28% . Pulmatrix (N… read more...
Microcaps mostly among midday movers
via: SeekingAlpha at 2019-03-08 07:57:19:000
Gainers: TrovaGene (NASDAQ: TROV ) +74% . Stellar Biotechnologies (NASDAQ: SBOT ) +51% . Tenax Therapeutics (NASDAQ: TENX ) +51% . Globus Maritime (NASDAQ: GLBS ) +47% . Seelos Therapeutics (NASDAQ: SEEL ) +36% . Tonix Pharmaceuticals Holding (NASDAQ: TNXP ) +28% . Pulmatrix (N… read more...
Microcaps mostly among midday movers
via: SeekingAlpha at 2019-03-08 07:57:19:000
Gainers: TrovaGene (NASDAQ: TROV ) +74% . Stellar Biotechnologies (NASDAQ: SBOT ) +51% . Tenax Therapeutics (NASDAQ: TENX ) +51% . Globus Maritime (NASDAQ: GLBS ) +47% . Seelos Therapeutics (NASDAQ: SEEL ) +36% . Tonix Pharmaceuticals Holding (NASDAQ: TNXP ) +28% . Pulmatrix (N… read more...
Microcaps mostly among midday movers
via: SeekingAlpha at 2019-03-08 07:57:19:000
Gainers: TrovaGene (NASDAQ: TROV ) +74% . Stellar Biotechnologies (NASDAQ: SBOT ) +51% . Tenax Therapeutics (NASDAQ: TENX ) +51% . Globus Maritime (NASDAQ: GLBS ) +47% . Seelos Therapeutics (NASDAQ: SEEL ) +36% . Tonix Pharmaceuticals Holding (NASDAQ: TNXP ) +28% . Pulmatrix (N… read more...
Altimmune down 33% on capital raise
via: SeekingAlpha at 2019-03-08 06:33:40:000
Providing a shining example of the risks in chasing tiny biotech breakouts, nano cap Altimmune ( ALT -32.8% ) slumps on more than a 5x surge in volume in reaction to its direct offering of 4,361,370 common units and pre-funded units at $3.21 per unit to two institutional investors. Gross p… read more...
Altimmune down 33% on capital raise
via: SeekingAlpha at 2019-03-08 06:33:40:000
Providing a shining example of the risks in chasing tiny biotech breakouts, nano cap Altimmune ( ALT -32.8% ) slumps on more than a 5x surge in volume in reaction to its direct offering of 4,361,370 common units and pre-funded units at $3.21 per unit to two institutional investors. Gross p… read more...
Altimmune down 33% on capital raise
via: SeekingAlpha at 2019-03-08 06:33:40:000
Providing a shining example of the risks in chasing tiny biotech breakouts, nano cap Altimmune ( ALT -32.8% ) slumps on more than a 5x surge in volume in reaction to its direct offering of 4,361,370 common units and pre-funded units at $3.21 per unit to two institutional investors. Gross p… read more...
Altimmune down 33% on capital raise
via: SeekingAlpha at 2019-03-08 06:33:40:000
Providing a shining example of the risks in chasing tiny biotech breakouts, nano cap Altimmune ( ALT -32.8% ) slumps on more than a 5x surge in volume in reaction to its direct offering of 4,361,370 common units and pre-funded units at $3.21 per unit to two institutional investors. Gross p… read more...
Altimmune down 33% on capital raise
via: SeekingAlpha at 2019-03-08 06:33:40:000
Providing a shining example of the risks in chasing tiny biotech breakouts, nano cap Altimmune ( ALT -32.8% ) slumps on more than a 5x surge in volume in reaction to its direct offering of 4,361,370 common units and pre-funded units at $3.21 per unit to two institutional investors. Gross p… read more...
Healthcare and Tech stocks among major premarket losers
via: SeekingAlpha at 2019-03-08 04:22:07:000
CHF Solutions (NASDAQ: CHFS ) -42% on equity offering . More news on: CHF Solutions, Inc., Eventbrite, Bio-Path Holdings, Inc., Stocks on the move, Read more … read more...
Healthcare and Tech stocks among major premarket losers
via: SeekingAlpha at 2019-03-08 04:22:07:000
CHF Solutions (NASDAQ: CHFS ) -42% on equity offering . More news on: CHF Solutions, Inc., Eventbrite, Bio-Path Holdings, Inc., Stocks on the move, Read more … read more...
Healthcare and Tech stocks among major premarket losers
via: SeekingAlpha at 2019-03-08 04:22:07:000
CHF Solutions (NASDAQ: CHFS ) -42% on equity offering . More news on: CHF Solutions, Inc., Eventbrite, Bio-Path Holdings, Inc., Stocks on the move, Read more … read more...
Healthcare and Tech stocks among major premarket losers
via: SeekingAlpha at 2019-03-08 04:22:07:000
CHF Solutions (NASDAQ: CHFS ) -42% on equity offering . More news on: CHF Solutions, Inc., Eventbrite, Bio-Path Holdings, Inc., Stocks on the move, Read more … read more...
Healthcare and Tech stocks among major premarket losers
via: SeekingAlpha at 2019-03-08 04:22:07:000
CHF Solutions (NASDAQ: CHFS ) -42% on equity offering . More news on: CHF Solutions, Inc., Eventbrite, Bio-Path Holdings, Inc., Stocks on the move, Read more … read more...
Healthcare tops midday movers
via: SeekingAlpha at 2019-03-07 07:53:29:000
Gainers: Bio-Path Holdings (NASDAQ: BPTH ) +201% . Seelos Therapeutics (NASDAQ: SEEL ) +79% . ArQule (NASDAQ: ARQL ) +66% . Altimmune (NASDAQ: ALT ) +60% . Rosetta Stone (NYSE: RST ) +31% . Calumet Specialty Products Partners (NASDAQ: CLMT ) +29% . Cleveland BioLabs (NASDAQ: CB… read more...
CLMT, RENN among premarket gainers
via: SeekingAlpha at 2019-03-07 04:14:44:000
Seelos Therapeutics (NASDAQ: SEEL ) +55% on acquisition an exclusive license to intellectual property owned byThe Regents of the University of California. More news on: Seelos Therapeutics Inc, Bio-Path Holdings, Inc., Altimmune, Inc., Stocks on the move, Read more … read more...
Altimmune up 44% premarket
via: SeekingAlpha at 2019-03-07 03:05:14:000
Nano cap Altimmune (NASDAQ: ALT ) is up 44% premarket on robust volume on no apparent news. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
After Hours Gainers / Losers
via: SeekingAlpha at 2019-03-06 12:33:03:000
Gainers: ALT +17.9% . HIIQ +9.7% . GWRE +8.1% . NGVC +7.0% . CMTL +7.0% . More news on: Altimmune, Inc., Health Insurance Innovations, Guidewire Software, Inc., Stocks on the move, Read more … read more...
Novavax: Anticipation Builds With Major Catalysts Just Around The Corner
via: SeekingAlpha at 2019-02-13 17:05:57:000
The Wait On The ResVax Preliminary Data Is Nearly Over A couple of months ago I wrote an article on Novavax ( NVAX ) detailing the upcoming catalysts set to hit in early 2019 stating the stock would remain in the $1.50-$2.50 price range as anticipation builds on the release of 2 main preli… read more...
Novavax: Anticipation Builds With Major Catalysts Just Around The Corner
via: SeekingAlpha at 2019-02-13 17:05:57:000
The Wait On The ResVax Preliminary Data Is Nearly Over A couple of months ago I wrote an article on Novavax ( NVAX ) detailing the upcoming catalysts set to hit in early 2019 stating the stock would remain in the $1.50-$2.50 price range as anticipation builds on the release of 2 main preli… read more...
Novavax: Anticipation Builds With Major Catalysts Just Around The Corner
via: SeekingAlpha at 2019-02-13 17:05:57:000
The Wait On The ResVax Preliminary Data Is Nearly Over A couple of months ago I wrote an article on Novavax ( NVAX ) detailing the upcoming catalysts set to hit in early 2019 stating the stock would remain in the $1.50-$2.50 price range as anticipation builds on the release of 2 main preli… read more...
Altimmune (ALT) Investor Presentation - Slideshow
via: SeekingAlpha at 2019-01-29 14:42:46:000
The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...
Altimmune (ALT) Investor Presentation - Slideshow
via: SeekingAlpha at 2019-01-29 14:42:46:000
The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...
Altimmune (ALT) Investor Presentation - Slideshow
via: SeekingAlpha at 2019-01-29 14:42:46:000
The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...
VALE, XRX among premarket gainers
via: SeekingAlpha at 2019-01-29 09:19:05:000
OncoCyte (NYSEMKT: OCX ) +132% on lung cancer liquid biopsy test results . More news on: OncoCyte Corporation, Voyager Therapeutics, Sanmina Corp, Stocks on the move, , Read more … read more...
VALE, XRX among premarket gainers
via: SeekingAlpha at 2019-01-29 09:19:05:000
OncoCyte (NYSEMKT: OCX ) +132% on lung cancer liquid biopsy test results . More news on: OncoCyte Corporation, Voyager Therapeutics, Sanmina Corp, Stocks on the move, , Read more … read more...
VALE, XRX among premarket gainers
via: SeekingAlpha at 2019-01-29 09:19:05:000
OncoCyte (NYSEMKT: OCX ) +132% on lung cancer liquid biopsy test results . More news on: OncoCyte Corporation, Voyager Therapeutics, Sanmina Corp, Stocks on the move, , Read more … read more...
Altimmune up 5% premarket ahead of HepTCell presentation
via: SeekingAlpha at 2019-01-29 09:14:30:000
Altimmune (NASDAQ: ALT ) is up 5% premarket on modestly higher volume in apparent response to is announcement that it will be presenting results from its recently completed Phase 1 clinical trial of HBV candidate HepTCell at EASL in Vienna in mid-April. More news on: Altimmun… read more...
Altimmune up 5% premarket ahead of HepTCell presentation
via: SeekingAlpha at 2019-01-29 09:14:30:000
Altimmune (NASDAQ: ALT ) is up 5% premarket on modestly higher volume in apparent response to is announcement that it will be presenting results from its recently completed Phase 1 clinical trial of HBV candidate HepTCell at EASL in Vienna in mid-April. More news on: Altimmun… read more...
Altimmune up 5% premarket ahead of HepTCell presentation
via: SeekingAlpha at 2019-01-29 09:14:30:000
Altimmune (NASDAQ: ALT ) is up 5% premarket on modestly higher volume in apparent response to is announcement that it will be presenting results from its recently completed Phase 1 clinical trial of HBV candidate HepTCell at EASL in Vienna in mid-April. More news on: Altimmun… read more...
SNAP, NM, LGCY and FDC among notable midday movers
via: SeekingAlpha at 2019-01-16 12:48:14:000
Gainers: ToughBuilt Industries (NASDAQ: TBLT ) +187% . Biocept (NASDAQ: BIOC ) +93% . Hancock Jaffe Laboratories (NASDAQ: HJLI ) +34% . Reebonz Holding ( RBZ ) +23% . Vaccinex (NASDAQ: VCNX ) +21% . First Data (NYSE: FDC ) +21% . Altimmune (NASDAQ: ALT ) +20% . CLPS Incorporat… read more...
SNAP, NM, LGCY and FDC among notable midday movers
via: SeekingAlpha at 2019-01-16 12:48:14:000
Gainers: ToughBuilt Industries (NASDAQ: TBLT ) +187% . Biocept (NASDAQ: BIOC ) +93% . Hancock Jaffe Laboratories (NASDAQ: HJLI ) +34% . Reebonz Holding ( RBZ ) +23% . Vaccinex (NASDAQ: VCNX ) +21% . First Data (NYSE: FDC ) +21% . Altimmune (NASDAQ: ALT ) +20% . CLPS Incorporat… read more...
SNAP, NM, LGCY and FDC among notable midday movers
via: SeekingAlpha at 2019-01-16 12:48:14:000
Gainers: ToughBuilt Industries (NASDAQ: TBLT ) +187% . Biocept (NASDAQ: BIOC ) +93% . Hancock Jaffe Laboratories (NASDAQ: HJLI ) +34% . Reebonz Holding ( RBZ ) +23% . Vaccinex (NASDAQ: VCNX ) +21% . First Data (NYSE: FDC ) +21% . Altimmune (NASDAQ: ALT ) +20% . CLPS Incorporat… read more...
Altimmune Reports Mixed Bag Of Updates
via: SeekingAlpha at 2018-12-17 14:56:18:000
Altimmune ( ALT ) recently released updates on their NasoShield and HepTcell programs. Similar to the March 2018 data release, the company provided a mix of positive and negative information, but the negative appears to outweigh the positive. Since the press release, the share price has fa… read more...
Altimmune Reports Mixed Bag Of Updates
via: SeekingAlpha at 2018-12-17 14:56:18:000
Altimmune ( ALT ) recently released updates on their NasoShield and HepTcell programs. Similar to the March 2018 data release, the company provided a mix of positive and negative information, but the negative appears to outweigh the positive. Since the press release, the share price has fa… read more...
Altimmune Reports Mixed Bag Of Updates
via: SeekingAlpha at 2018-12-17 14:56:18:000
Altimmune ( ALT ) recently released updates on their NasoShield and HepTcell programs. Similar to the March 2018 data release, the company provided a mix of positive and negative information, but the negative appears to outweigh the positive. Since the press release, the share price has fa… read more...
Healthcare and consumer stocks down in premarket trade
via: SeekingAlpha at 2018-12-13 09:12:40:000
Applied Genetic Technologies (NASDAQ: AGTC ) -38% after gene therapy fails to show effect in XLRS study. More news on: Applied Genetic Technologies Corporation, Tailored Brands, Inc, Marinus Pharmaceuticals, Stocks on the move, , Read more … read more...
Healthcare and consumer stocks down in premarket trade
via: SeekingAlpha at 2018-12-13 09:12:40:000
Applied Genetic Technologies (NASDAQ: AGTC ) -38% after gene therapy fails to show effect in XLRS study. More news on: Applied Genetic Technologies Corporation, Tailored Brands, Inc, Marinus Pharmaceuticals, Stocks on the move, , Read more … read more...
Healthcare and consumer stocks down in premarket trade
via: SeekingAlpha at 2018-12-13 09:12:40:000
Applied Genetic Technologies (NASDAQ: AGTC ) -38% after gene therapy fails to show effect in XLRS study. More news on: Applied Genetic Technologies Corporation, Tailored Brands, Inc, Marinus Pharmaceuticals, Stocks on the move, , Read more … read more...
Altimmune slips 5% premarket on disappointing NasoShield data
via: SeekingAlpha at 2018-12-13 08:39:06:000
Nano cap Altimmune (NASDAQ: ALT ) is down 5% premarket on light volume on the heels of it update for investors on its pipeline activities. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune slips 5% premarket on disappointing NasoShield data
via: SeekingAlpha at 2018-12-13 08:39:06:000
Nano cap Altimmune (NASDAQ: ALT ) is down 5% premarket on light volume on the heels of it update for investors on its pipeline activities. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune slips 5% premarket on disappointing NasoShield data
via: SeekingAlpha at 2018-12-13 08:39:06:000
Nano cap Altimmune (NASDAQ: ALT ) is down 5% premarket on light volume on the heels of it update for investors on its pipeline activities. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune: Suppressed, Immature, Or Dormant?
via: SeekingAlpha at 2018-12-05 15:22:22:000
2018 has been a volatile year for Altimmune ( ALT ) from start to finish. The company experienced mixed results in clinical trials as well as changes management positions. Unfortunately, the share price has taken the brunt of the losses and has gained little from the wins. After a reverse spli… read more...
Altimmune: Suppressed, Immature, Or Dormant?
via: SeekingAlpha at 2018-12-05 15:22:22:000
2018 has been a volatile year for Altimmune ( ALT ) from start to finish. The company experienced mixed results in clinical trials as well as changes management positions. Unfortunately, the share price has taken the brunt of the losses and has gained little from the wins. After a reverse spli… read more...
Altimmune: Suppressed, Immature, Or Dormant?
via: SeekingAlpha at 2018-12-05 15:22:22:000
2018 has been a volatile year for Altimmune ( ALT ) from start to finish. The company experienced mixed results in clinical trials as well as changes management positions. Unfortunately, the share price has taken the brunt of the losses and has gained little from the wins. After a reverse spli… read more...
Altimmune up 7% premarket after Q3 update
via: SeekingAlpha at 2018-11-14 08:58:56:000
Altimmune (NASDAQ: ALT ) is up 7% premarket on light volume in response to its Q3 report released after the close yesterday. Highlights: More news on: Altimmune, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more … read more...
Altimmune up 7% premarket after Q3 update
via: SeekingAlpha at 2018-11-14 08:58:56:000
Altimmune (NASDAQ: ALT ) is up 7% premarket on light volume in response to its Q3 report released after the close yesterday. Highlights: More news on: Altimmune, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more … read more...
Altimmune up 7% premarket after Q3 update
via: SeekingAlpha at 2018-11-14 08:58:56:000
Altimmune (NASDAQ: ALT ) is up 7% premarket on light volume in response to its Q3 report released after the close yesterday. Highlights: More news on: Altimmune, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more … read more...
Altimmune reports Q3 results
via: SeekingAlpha at 2018-11-13 16:54:15:000
Altimmune (NASDAQ: ALT ): Q3 GAAP EPS of -$1.73. More news on: Altimmune, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Altimmune (ALT) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - Slideshow
via: SeekingAlpha at 2018-10-31 18:03:28:000
The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...
Altimmune (ALT) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - Slideshow
via: SeekingAlpha at 2018-10-31 18:03:28:000
The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...
Altimmune (ALT) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - Slideshow
via: SeekingAlpha at 2018-10-31 18:03:28:000
The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...
Midday Gainers / Losers (10/16/2018)
via: SeekingAlpha at 2018-10-16 12:44:53:000
Gainers: FFHL +73% . BLNK +38% . GTXI +26% . ALRN +22% . IFMK +18% . ALT +18% . HQCL +17% . NDLS +15% . SEND +15% . HMNY +15% . More news on: Fuwei Films (Holdings) Co., Ltd., Blink Charging Co., GTx, Inc., Stocks on the move, , Top stock market news, … read more...
Midday Gainers / Losers (10/16/2018)
via: SeekingAlpha at 2018-10-16 12:44:53:000
Gainers: FFHL +73% . BLNK +38% . GTXI +26% . ALRN +22% . IFMK +18% . ALT +18% . HQCL +17% . NDLS +15% . SEND +15% . HMNY +15% . More news on: Fuwei Films (Holdings) Co., Ltd., Blink Charging Co., GTx, Inc., Stocks on the move, , Top stock market news, … read more...
Midday Gainers / Losers (10/16/2018)
via: SeekingAlpha at 2018-10-16 12:44:53:000
Gainers: FFHL +73% . BLNK +38% . GTXI +26% . ALRN +22% . IFMK +18% . ALT +18% . HQCL +17% . NDLS +15% . SEND +15% . HMNY +15% . More news on: Fuwei Films (Holdings) Co., Ltd., Blink Charging Co., GTx, Inc., Stocks on the move, , Top stock market news, … read more...
Weekly market movement wrap
via: SeekingAlpha at 2018-10-13 17:35:40:000
See a week over week comparison below for the following indices, equities, commodities, bonds and currencies. More news on: Youngevity International, Inc., CorMedix Inc., Pyxus International, Inc., Top stock market news, Quick stock ideas, News on the U.S. economy, Financial stocks news, H… read more...
Weekly market movement wrap
via: SeekingAlpha at 2018-10-13 17:35:40:000
See a week over week comparison below for the following indices, equities, commodities, bonds and currencies. More news on: Youngevity International, Inc., CorMedix Inc., Pyxus International, Inc., Top stock market news, Quick stock ideas, News on the U.S. economy, Financial stocks news, H… read more...
Weekly market movement wrap
via: SeekingAlpha at 2018-10-13 17:35:40:000
See a week over week comparison below for the following indices, equities, commodities, bonds and currencies. More news on: Youngevity International, Inc., CorMedix Inc., Pyxus International, Inc., Top stock market news, Quick stock ideas, News on the U.S. economy, Financial stocks news, H… read more...
Altimmune Declines Too Much
via: SeekingAlpha at 2018-10-09 15:41:37:000
Currently trading at 0.52x its book value per share after several equity transactions, Altimmune (ALT) seems a bit undervalued as compared to peers. The company sold large amount of warrants that investors should not appreciate. With that, other peers are trading at 1.95x-4.4x book value per s… read more...
Altimmune Declines Too Much
via: SeekingAlpha at 2018-10-09 15:41:37:000
Currently trading at 0.52x its book value per share after several equity transactions, Altimmune (ALT) seems a bit undervalued as compared to peers. The company sold large amount of warrants that investors should not appreciate. With that, other peers are trading at 1.95x-4.4x book value per s… read more...
Altimmune Declines Too Much
via: SeekingAlpha at 2018-10-09 15:41:37:000
Currently trading at 0.52x its book value per share after several equity transactions, Altimmune (ALT) seems a bit undervalued as compared to peers. The company sold large amount of warrants that investors should not appreciate. With that, other peers are trading at 1.95x-4.4x book value per s… read more...
Altimmune announces $25M registered direct offering; shares down 31% premarket
via: SeekingAlpha at 2018-10-08 09:28:04:000
Altimmune (NASDAQ: ALT ) has entered into a purchase agreement with several institutional investors for the purchase of common units and pre-funded units for a combined total of 4,629,630 units in a registered direct offering, for expected gross proceeds of ~$25M. More news on: Altimmune… read more...
Premarket Losers as of 9:05 am (10/8/2018)
via: SeekingAlpha at 2018-10-08 09:08:23:000
ALT -32% on announcing $25M registered direct offering. More news on: Altimmune, Inc., vTv Therapeutics, GTx, Inc., Stocks on the move, Top stock market news, , Read more … read more...
Midday Gainers / Losers (10/01/2018)
via: SeekingAlpha at 2018-10-01 12:40:08:000
Gainers: OGEN +51% . LEVB +37% . NBEV +39% . ARCW +30% . NTGN +27% . IGC +25% . IFMK +24% . ACST +21% . ATLC +21% . ALT +21% . More news on: Oragenics, Inc., Level Brands, Inc., New Age Beverages Corporation, Stocks on the move, , Read more … read more...
Midday Gainers / Losers (10/01/2018)
via: SeekingAlpha at 2018-10-01 12:40:08:000
Gainers: OGEN +51% . LEVB +37% . NBEV +39% . ARCW +30% . NTGN +27% . IGC +25% . IFMK +24% . ACST +21% . ATLC +21% . ALT +21% . More news on: Oragenics, Inc., Level Brands, Inc., New Age Beverages Corporation, Stocks on the move, , Read more … read more...
Midday Gainers / Losers (10/01/2018)
via: SeekingAlpha at 2018-10-01 12:40:08:000
Gainers: OGEN +51% . LEVB +37% . NBEV +39% . ARCW +30% . NTGN +27% . IGC +25% . IFMK +24% . ACST +21% . ATLC +21% . ALT +21% . More news on: Oragenics, Inc., Level Brands, Inc., New Age Beverages Corporation, Stocks on the move, , Read more … read more...
Midday Gainers / Losers (09/28/2018)
via: SeekingAlpha at 2018-09-28 12:40:43:000
Gainers: SYN +207% . IGC +36% . NBEV +31% . AYTU +23% . ZN +21% . CCXI +17% . IMMP +14% . SPNS +14% . PRSS +13% . AC +12% . More news on: Synthetic Biologics, Inc., India Globalization Capital, Inc, New Age Beverages Corporation, Stocks on the move, , Top s… read more...
Midday Gainers / Losers (09/28/2018)
via: SeekingAlpha at 2018-09-28 12:40:43:000
Gainers: SYN +207% . IGC +36% . NBEV +31% . AYTU +23% . ZN +21% . CCXI +17% . IMMP +14% . SPNS +14% . PRSS +13% . AC +12% . More news on: Synthetic Biologics, Inc., India Globalization Capital, Inc, New Age Beverages Corporation, Stocks on the move, , Top s… read more...
Midday Gainers / Losers (09/28/2018)
via: SeekingAlpha at 2018-09-28 12:40:43:000
Gainers: SYN +207% . IGC +36% . NBEV +31% . AYTU +23% . ZN +21% . CCXI +17% . IMMP +14% . SPNS +14% . PRSS +13% . AC +12% . More news on: Synthetic Biologics, Inc., India Globalization Capital, Inc, New Age Beverages Corporation, Stocks on the move, , Top s… read more...
Altimmune prices equity offering at $5/unit; shares down 49% premarket
via: SeekingAlpha at 2018-09-28 09:18:49:000
Thinly traded nano cap Altimmune (NASDAQ: ALT ) slumps 49% premarket on increased volume in response to its public offering of 2.4M unts at $5/unit. Each unit consists of one common share and one five-year warrant to purchase one common share at $6.00. More news on: Altimmune… read more...
Altimmune prices equity offering at $5/unit; shares down 49% premarket
via: SeekingAlpha at 2018-09-28 09:18:49:000
Thinly traded nano cap Altimmune (NASDAQ: ALT ) slumps 49% premarket on increased volume in response to its public offering of 2.4M unts at $5/unit. Each unit consists of one common share and one five-year warrant to purchase one common share at $6.00. More news on: Altimmune… read more...
Altimmune prices equity offering at $5/unit; shares down 49% premarket
via: SeekingAlpha at 2018-09-28 09:18:49:000
Thinly traded nano cap Altimmune (NASDAQ: ALT ) slumps 49% premarket on increased volume in response to its public offering of 2.4M unts at $5/unit. Each unit consists of one common share and one five-year warrant to purchase one common share at $6.00. More news on: Altimmune… read more...
Premarket Losers as of 9:05 am (9/28/2018)
via: SeekingAlpha at 2018-09-28 09:15:12:000
ALT -48% on pricing $12M Public Offering. More news on: Altimmune, Inc., Geron Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (9/28/2018)
via: SeekingAlpha at 2018-09-28 09:15:12:000
ALT -48% on pricing $12M Public Offering. More news on: Altimmune, Inc., Geron Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (9/28/2018)
via: SeekingAlpha at 2018-09-28 09:15:12:000
ALT -48% on pricing $12M Public Offering. More news on: Altimmune, Inc., Geron Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Midday Gainers / Losers (09/27/2018)
via: SeekingAlpha at 2018-09-27 12:40:42:000
Gainers: ACHV +58% . RXII +36% . IGC +26% . GBR +25% . HAIR +20% . YGYI +18% . NTGN +17% . LQDA +16% . ARAY +17% . CCJ +16% . More news on: Achieve Life Sciences, Inc., RXI Pharmaceuticals Corporation, India Globalization Capital, Inc, Stocks on the mo… read more...
Altimmune readies equity offering; shares down 4% after hours
via: SeekingAlpha at 2018-09-26 21:37:49:000
Altimmune (NASDAQ: ALT ) has filed a preliminary prospectus for a public offering of 1,438,848 Common Units and the same number of Pre-Funded Units. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Midday Gainers / Losers (09/26/2018)
via: SeekingAlpha at 2018-09-26 12:40:49:000
Gainers: ALDX +60% . VLRX +25% . IGC +23% . AGMH +21% . ELMD +21% . XOMA +13% . GWGH +13% . LQDA +13% . AVXL +14% . MMYT +12% . More news on: Aldeyra Therapeutics, Inc., Valeritas Holdings, Inc., India Globalization Capital, Inc, Stocks on the move, , Top s… read more...
Midday Gainers / Losers (09/24/2018)
via: SeekingAlpha at 2018-09-24 12:35:13:000
Gainers: AMRN +233% . SAEX +153% . GBR +41% . JONE +27% . IPCI +26% . XON +23% . CRC +17% . AGTC +16% . PEIX +15% . ACHV +15% . More news on: Amarin Corporation PLC, SAExploration Holdings, Inc., New Concept Energy, Inc., , Stocks on the move, Top stoc… read more...
Midday Gainers / Losers (09/24/2018)
via: SeekingAlpha at 2018-09-24 12:35:13:000
Gainers: AMRN +233% . SAEX +153% . GBR +41% . JONE +27% . IPCI +26% . XON +23% . CRC +17% . AGTC +16% . PEIX +15% . ACHV +15% . More news on: Amarin Corporation PLC, SAExploration Holdings, Inc., New Concept Energy, Inc., , Stocks on the move, Top stoc… read more...
Midday Gainers / Losers (09/20/2018)
via: SeekingAlpha at 2018-09-20 12:43:20:000
Gainers: ASCMA +95% . NBEV +64% . NVMM +47% . ALT +40% . CRBP +36% . AWSM +35% . YGYI +27% . LEVB +27% . OSN +21% . NIHD +20% . More news on: Ascent Capital Group, Inc., New Age Beverages Corporation, NOVUME SOLUTIONS INC, Stocks on the move, , Top sto… read more...
Midday Gainers / Losers (09/20/2018)
via: SeekingAlpha at 2018-09-20 12:43:20:000
Gainers: ASCMA +95% . NBEV +64% . NVMM +47% . ALT +40% . CRBP +36% . AWSM +35% . YGYI +27% . LEVB +27% . OSN +21% . NIHD +20% . More news on: Ascent Capital Group, Inc., New Age Beverages Corporation, NOVUME SOLUTIONS INC, Stocks on the move, , Top sto… read more...
Midday Gainers / Losers (09/20/2018)
via: SeekingAlpha at 2018-09-20 12:43:20:000
Gainers: ASCMA +95% . NBEV +64% . NVMM +47% . ALT +40% . CRBP +36% . AWSM +35% . YGYI +27% . LEVB +27% . OSN +21% . NIHD +20% . More news on: Ascent Capital Group, Inc., New Age Beverages Corporation, NOVUME SOLUTIONS INC, Stocks on the move, , Top sto… read more...
Vaxart up 12%
via: SeekingAlpha at 2018-09-20 11:16:19:000
Thinly traded nano cap Vaxart ( VXRT +12.4% ) is up 42% higher volume, albeit on modest turnover of 30K shares. The action appears to be connected to the rally in Altimmune ( ALT +72.1% ), up almost seven-fold in two days after announcing positive mid-stage data on flu vaccine candidate … read more...
Vaxart up 12%
via: SeekingAlpha at 2018-09-20 11:16:19:000
Thinly traded nano cap Vaxart ( VXRT +12.4% ) is up 42% higher volume, albeit on modest turnover of 30K shares. The action appears to be connected to the rally in Altimmune ( ALT +72.1% ), up almost seven-fold in two days after announcing positive mid-stage data on flu vaccine candidate … read more...
Vaxart up 12%
via: SeekingAlpha at 2018-09-20 11:16:19:000
Thinly traded nano cap Vaxart ( VXRT +12.4% ) is up 42% higher volume, albeit on modest turnover of 30K shares. The action appears to be connected to the rally in Altimmune ( ALT +72.1% ), up almost seven-fold in two days after announcing positive mid-stage data on flu vaccine candidate … read more...
Premarket Losers as of 9:05 am (9/20/2018)
via: SeekingAlpha at 2018-09-20 09:10:15:000
RRTS -15% on announcing plans for rights offering. More news on: Roadrunner Transportation Systems, Inc., Molecular Templates, Inc., Altimmune, Inc., Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (9/20/2018)
via: SeekingAlpha at 2018-09-20 09:10:15:000
RRTS -15% on announcing plans for rights offering. More news on: Roadrunner Transportation Systems, Inc., Molecular Templates, Inc., Altimmune, Inc., Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (9/20/2018)
via: SeekingAlpha at 2018-09-20 09:10:15:000
RRTS -15% on announcing plans for rights offering. More news on: Roadrunner Transportation Systems, Inc., Molecular Templates, Inc., Altimmune, Inc., Stocks on the move, Top stock market news, , Read more … read more...
Midday Gainers / Losers (09/19/2018)
via: SeekingAlpha at 2018-09-19 12:40:20:000
Gainers: ALT +71% . MTEM +67% . DCTH +61% . MOC +47% . TLRY +46% . NBEV +34% . IGC +21% . SAEX +21% . CRON +18% . NTEC +17% . More news on: Altimmune, Inc., Molecular Templates, Inc., Delcath Systems, Inc., Stocks on the move, , Top stock market news, … read more...
Altimmune jumps 99%
via: SeekingAlpha at 2018-09-19 11:13:28:000
Thinly traded nano cap Altimmune ( ALT +99.1% ) is up on an 11x surge in volume, albeit on turnover of only 387K shares. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune -9.1% on offering of 58M units
via: SeekingAlpha at 2018-08-17 17:26:54:000
Altimmune (NASDAQ: ALT ) is off 9.1% after hours following a registration to offer nearly 58M units . More news on: Altimmune, Inc., Stocks on the move, Healthcare stocks news, Read more … read more...
Altimmune -9.1% on offering of 58M units
via: SeekingAlpha at 2018-08-17 17:26:54:000
Altimmune (NASDAQ: ALT ) is off 9.1% after hours following a registration to offer nearly 58M units . More news on: Altimmune, Inc., Stocks on the move, Healthcare stocks news, Read more … read more...
Altimmune -9.1% on offering of 58M units
via: SeekingAlpha at 2018-08-17 17:26:54:000
Altimmune (NASDAQ: ALT ) is off 9.1% after hours following a registration to offer nearly 58M units . More news on: Altimmune, Inc., Stocks on the move, Healthcare stocks news, Read more … read more...
Altimmune -9.1% on offering of 58M units
via: SeekingAlpha at 2018-08-17 17:26:54:000
Altimmune (NASDAQ: ALT ) is off 9.1% after hours following a registration to offer nearly 58M units . More news on: Altimmune, Inc., Stocks on the move, Healthcare stocks news, Read more … read more...
Altimmune -9.1% on offering of 58M units
via: SeekingAlpha at 2018-08-17 17:26:54:000
Altimmune (NASDAQ: ALT ) is off 9.1% after hours following a registration to offer nearly 58M units . More news on: Altimmune, Inc., Stocks on the move, Healthcare stocks news, Read more … read more...
Altimmune, Inc (ALT) CEO Bill Enright on Q2 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-08-15 10:05:05:000
Altimmune, Inc. (ALT) Q2 2018 Results Earnings Conference Call August 15, 2018, 08:30 AM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts Presentation Operator Good morning everyone and welcome to the Altimmune Second Quarter 2018 Earnings Conference … read more...
Altimmune, Inc (ALT) CEO Bill Enright on Q2 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-08-15 10:05:05:000
Altimmune, Inc. (ALT) Q2 2018 Results Earnings Conference Call August 15, 2018, 08:30 AM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts Presentation Operator Good morning everyone and welcome to the Altimmune Second Quarter 2018 Earnings Conference … read more...
Altimmune misses by $0.19, misses on revenue
via: SeekingAlpha at 2018-08-14 16:27:24:000
Altimmune (NASDAQ: ALT ): Q2 EPS of -$0.34 misses by $0.19 . Revenue of $2.41M (-20.7% Y/Y) misses by $0.6M . Shares +2.5% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
Altimmune -16% on securities offering
via: SeekingAlpha at 2018-07-30 17:58:39:000
Nanocap Altimmune (NASDAQ: ALT ) has dropped 16.2% after hours after filing to offer up to $24M in units , via Roth Capital Partners. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune -16% on securities offering
via: SeekingAlpha at 2018-07-30 17:58:39:000
Nanocap Altimmune (NASDAQ: ALT ) has dropped 16.2% after hours after filing to offer up to $24M in units , via Roth Capital Partners. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune -16% on securities offering
via: SeekingAlpha at 2018-07-30 17:58:39:000
Nanocap Altimmune (NASDAQ: ALT ) has dropped 16.2% after hours after filing to offer up to $24M in units , via Roth Capital Partners. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
A High-Throughput Screen For Cancer Stocks That Have Few (Or No) Fundamentals
via: SeekingAlpha at 2018-06-16 09:00:00:000
Author's note: This article was presented early to subscribers of the Total Pharma Tracker , and they also got further insight into how best to use these tools in making investment decisions. Biotech holds a special place in my heart, both for the way it captures the imagination and for… read more...
A High-Throughput Screen For Cancer Stocks That Have Few (Or No) Fundamentals
via: SeekingAlpha at 2018-06-16 09:00:00:000
Author's note: This article was presented early to subscribers of the Total Pharma Tracker , and they also got further insight into how best to use these tools in making investment decisions. Biotech holds a special place in my heart, both for the way it captures the imagination and for… read more...
A High-Throughput Screen For Cancer Stocks That Have Few (Or No) Fundamentals
via: SeekingAlpha at 2018-06-16 09:00:00:000
Author's note: This article was presented early to subscribers of the Total Pharma Tracker , and they also got further insight into how best to use these tools in making investment decisions. Biotech holds a special place in my heart, both for the way it captures the imagination and for… read more...
A High-Throughput Screen For Cancer Stocks That Have Few (Or No) Fundamentals
via: SeekingAlpha at 2018-06-16 09:00:00:000
Author's note: This article was presented early to subscribers of the Total Pharma Tracker , and they also got further insight into how best to use these tools in making investment decisions. Biotech holds a special place in my heart, both for the way it captures the imagination and for… read more...
Altimmune's (ALT) CEO Bill Enright on Q1 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-05-16 11:47:07:000
Altimmune, Inc. (ALT) Q1 2018 Results Earnings Conference Call May 16, 2018 05:00 PM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts David Sherman - LifeSci Capital Presentation Operator Good day and welcome to the Altimmune First Quarter 2018 Earn… read more...
Altimmune's (ALT) CEO Bill Enright on Q1 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-05-16 11:47:07:000
Altimmune, Inc. (ALT) Q1 2018 Results Earnings Conference Call May 16, 2018 05:00 PM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts David Sherman - LifeSci Capital Presentation Operator Good day and welcome to the Altimmune First Quarter 2018 Earn… read more...
Altimmune's (ALT) CEO Bill Enright on Q1 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-05-16 11:47:07:000
Altimmune, Inc. (ALT) Q1 2018 Results Earnings Conference Call May 16, 2018 05:00 PM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts David Sherman - LifeSci Capital Presentation Operator Good day and welcome to the Altimmune First Quarter 2018 Earn… read more...
Altimmune's (ALT) CEO Bill Enright on Q1 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-05-16 11:47:07:000
Altimmune, Inc. (ALT) Q1 2018 Results Earnings Conference Call May 16, 2018 05:00 PM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts David Sherman - LifeSci Capital Presentation Operator Good day and welcome to the Altimmune First Quarter 2018 Earn… read more...
Altimmune's (ALT) CEO Bill Enright on Q1 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-05-16 11:47:07:000
Altimmune, Inc. (ALT) Q1 2018 Results Earnings Conference Call May 16, 2018 05:00 PM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts David Sherman - LifeSci Capital Presentation Operator Good day and welcome to the Altimmune First Quarter 2018 Earn… read more...
Altimmune's (ALT) CEO Bill Enright on Q1 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-05-16 11:47:07:000
Altimmune, Inc. (ALT) Q1 2018 Results Earnings Conference Call May 16, 2018 05:00 PM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts David Sherman - LifeSci Capital Presentation Operator Good day and welcome to the Altimmune First Quarter 2018 Earn… read more...
Altimmune beats by $0.27, beats on revenue
via: SeekingAlpha at 2018-05-15 16:52:55:000
Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.7M (+800.0% Y/Y) beats by $1.5M . Shares +14.3% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
Altimmune beats by $0.27, beats on revenue
via: SeekingAlpha at 2018-05-15 16:52:55:000
Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.7M (+800.0% Y/Y) beats by $1.5M . Shares +14.3% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
Altimmune beats by $0.27, beats on revenue
via: SeekingAlpha at 2018-05-15 16:52:55:000
Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.7M (+800.0% Y/Y) beats by $1.5M . Shares +14.3% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
Altimmune beats by $0.27, beats on revenue
via: SeekingAlpha at 2018-05-15 16:52:55:000
Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.7M (+800.0% Y/Y) beats by $1.5M . Shares +14.3% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
Altimmune beats by $0.27, beats on revenue
via: SeekingAlpha at 2018-05-15 16:52:55:000
Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.7M (+800.0% Y/Y) beats by $1.5M . Shares +14.3% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
Altimmune beats by $0.27, beats on revenue
via: SeekingAlpha at 2018-05-15 16:52:55:000
Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.7M (+800.0% Y/Y) beats by $1.5M . Shares +14.3% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
Altimmune beats by $0.27, beats on revenue
via: SeekingAlpha at 2018-05-15 16:26:51:000
Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.69M (+796.7% Y/Y) beats by $1.49M . Shares +10% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
Altimmune beats by $0.27, beats on revenue
via: SeekingAlpha at 2018-05-15 16:26:51:000
Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.69M (+796.7% Y/Y) beats by $1.49M . Shares +10% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
Altimmune beats by $0.27, beats on revenue
via: SeekingAlpha at 2018-05-15 16:26:51:000
Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.69M (+796.7% Y/Y) beats by $1.49M . Shares +10% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
Altimmune beats by $0.27, beats on revenue
via: SeekingAlpha at 2018-05-15 16:26:51:000
Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.69M (+796.7% Y/Y) beats by $1.49M . Shares +10% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
Altimmune beats by $0.27, beats on revenue
via: SeekingAlpha at 2018-05-15 16:26:51:000
Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.69M (+796.7% Y/Y) beats by $1.49M . Shares +10% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
Altimmune beats by $0.27, beats on revenue
via: SeekingAlpha at 2018-05-15 16:26:51:000
Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.69M (+796.7% Y/Y) beats by $1.49M . Shares +10% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...
FDA accepts Sanofi Pasteur's marketing application for expanded use of flu vaccine
via: SeekingAlpha at 2018-04-25 09:45:07:000
The FDA accepts for review Sanofi Pasteur's ( SNY +0.6% ) supplemental marketing application seeking approval to use the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) in children ages six months to 35 months. It is is currently approved for use in kids at least 36 months of age… read more...
FDA accepts Sanofi Pasteur's marketing application for expanded use of flu vaccine
via: SeekingAlpha at 2018-04-25 09:45:07:000
The FDA accepts for review Sanofi Pasteur's ( SNY +0.6% ) supplemental marketing application seeking approval to use the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) in children ages six months to 35 months. It is is currently approved for use in kids at least 36 months of age… read more...
Altimmune (ALT) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow
via: SeekingAlpha at 2018-04-11 14:35:35:000
The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...
Altimmune (ALT) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow
via: SeekingAlpha at 2018-04-11 14:35:35:000
The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...
Altimmune's (ALT) CEO Bill Enright on Q4 2017 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-03-29 10:55:07:000
Altimmune, Inc. (ALT) Q4 2017 Earnings Conference Call March 29, 2018 08:00 ET Executives Paul Arndt - Investor Relations Bill Enright - Chief Executive Officer Elizabeth Czerepak - Chief Financial Officer and Executive Vice President, Corporate Development Sybil Tasker - Chief… read more...
Altimmune's (ALT) CEO Bill Enright on Q4 2017 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-03-29 10:55:07:000
Altimmune, Inc. (ALT) Q4 2017 Earnings Conference Call March 29, 2018 08:00 ET Executives Paul Arndt - Investor Relations Bill Enright - Chief Executive Officer Elizabeth Czerepak - Chief Financial Officer and Executive Vice President, Corporate Development Sybil Tasker - Chief… read more...
Altimmune reports FY results
via: SeekingAlpha at 2018-03-28 16:49:04:000
Altimmune (NASDAQ: ALT ): FY EPS of -$1.21 Revenue of $10.7M (+234.4% Y/Y) Press Release More news on: Altimmune, Inc., Earnings news and commentary, Healthcare stocks news, , read more...
Altimmune reports FY results
via: SeekingAlpha at 2018-03-28 16:49:04:000
Altimmune (NASDAQ: ALT ): FY EPS of -$1.21 Revenue of $10.7M (+234.4% Y/Y) Press Release More news on: Altimmune, Inc., Earnings news and commentary, Healthcare stocks news, , read more...
Midday Gainers / Losers (03/27/2018)
via: SeekingAlpha at 2018-03-27 12:59:05:000
Gainers: ASTC +32% . SHOS +31% . NSPR +28% . INNT +15% . TOPS +13% . MBII +13% . PETX +12% . HMNY +12% . ATNX +11% . MYOV +10% . More news on: Astrotech Corporation, Sears Hometown and Outlet Stores, Inc., InspireMD, Inc., , Read more … read more...
Midday Gainers / Losers (03/27/2018)
via: SeekingAlpha at 2018-03-27 12:59:05:000
Gainers: ASTC +32% . SHOS +31% . NSPR +28% . INNT +15% . TOPS +13% . MBII +13% . PETX +12% . HMNY +12% . ATNX +11% . MYOV +10% . More news on: Astrotech Corporation, Sears Hometown and Outlet Stores, Inc., InspireMD, Inc., , Read more … read more...
Premarket Gainers as of 9:05 am (03/13/2018)
via: SeekingAlpha at 2018-03-13 09:22:43:000
SPEX +52% to enter into cyber security market via DatChat acquisition. More news on: Spherix Incorporated, Proteostasis Therapeutics, Future Fintech Group Inc, Stocks on the move, , Read more … read more...
Premarket Gainers as of 9:05 am (03/13/2018)
via: SeekingAlpha at 2018-03-13 09:22:43:000
SPEX +52% to enter into cyber security market via DatChat acquisition. More news on: Spherix Incorporated, Proteostasis Therapeutics, Future Fintech Group Inc, Stocks on the move, , Read more … read more...
Altimmune +16% after data from anthrax vaccine program
via: SeekingAlpha at 2018-03-12 18:35:56:000
Altimmune (NASDAQ: ALT ) +16.6% after-hours following release of pre-clinical data from its SparVax-L anthrax vaccine program. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune +16% after data from anthrax vaccine program
via: SeekingAlpha at 2018-03-12 18:35:56:000
Altimmune (NASDAQ: ALT ) +16.6% after-hours following release of pre-clinical data from its SparVax-L anthrax vaccine program. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Altimmune (ALT) Presents At Noble Financial Capital Markets 14th Annual Investor Conference - Slideshow
via: SeekingAlpha at 2018-01-31 13:21:16:000
The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...
Altimmune (ALT) Presents At Noble Financial Capital Markets 14th Annual Investor Conference - Slideshow
via: SeekingAlpha at 2018-01-31 13:21:16:000
The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...
Altimmune (ALT) Presents At Noble Financial Capital Markets 14th Annual Investor Conference - Slideshow
via: SeekingAlpha at 2018-01-31 13:21:16:000
The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...
Your Daily Pharma Scoop: ChemoCentryx Surges, Akebia Gets Positive News, Atara Prices Public Offering
via: SeekingAlpha at 2018-01-05 01:36:56:000
Analysis of top Seeking Alpha coverage: ChemoCentryx Today we will discuss an update from ChemoCentryx ( CCXI ), which sent shares more than 30% higher in intra-day trading. ChemoCentryx is primarily focused on orphan and rare diseases. The companys lead product candidate is Avac… read more...
Your Daily Pharma Scoop: Ardelyx Reports Data, Omeros Moves Forward With OMS721, Allergan Announces Job Cuts
via: SeekingAlpha at 2018-01-04 02:17:49:000
Analysis of top Seeking Alpha coverage: Ardelyx Today we will discuss the announcement from Ardelyx ( ARDX ) with regards to the Phase 3 T3MPO program. The T3MPO program was designed to support the registration of tenapanor for the treatment of patients with irritable bowel syndrome with… read more...
Your Daily Pharma Scoop: Heron Enters 2018 On Strong Note, Teva Launches Generic Reyataz, Sarepta Top Smid-Cap Pick
via: SeekingAlpha at 2017-12-29 01:58:47:000
Analysis of top Seeking Alpha coverage: Heron Therapeutics Today we will be discussing one of the top performing stocks in the biotech sector this year, Heron Therapeutics ( HRTX ). After two disappointing years, HRTX is headed for gains of more than 40% for this year. Despite the rally, H… read more...
Premarket Gainers as of 9:05 am
via: SeekingAlpha at 2017-12-21 09:28:57:000
LTEA +351% on shifting its primary corporate focus towards the exploration of and investment in opportunities that leverage the benefits of blockchain technology. More news on: Long Island Iced Tea Corp., AEterna Zentaris, Inc., Net Element International, Inc., Stocks on the mo… read more...
Your Daily Pharma Scoop: Gilead's Potential, Celgene CAR-T Candidate, Cellectar Soars
via: SeekingAlpha at 2017-12-07 08:00:00:000
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Total Pharma Tracker subscribers get the full version with actionable ideas one day ea… read more...
Your Daily Pharma Scoop: Dynavax Beyond Heplisav-B, Novartis' Cosentyx, Shire Granted ODD
via: SeekingAlpha at 2017-12-01 12:47:33:000
This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Dynavax Today we will focus on an article on Dynavax… read more...
Your Daily Pharma Scoop: Synergy In 2018, Repatha Action Date, Alkermes Signs Deal
via: SeekingAlpha at 2017-11-28 07:43:47:000
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Synergy Pharma Today we will critique … read more...
Altimmune's (ALT) CEO Bill Enright on Q3 2017 Results - Earnings Call Transcript
via: SeekingAlpha at 2017-11-10 15:16:13:000
Altimmune, Inc. (ALT) Q3 2017 Earnings Conference Call November 10, 2017 08:30 ET Executives Ashley Robinson - Investor Relations Bill Enright - Chief Executive Officer Elizabeth Czerepak - Chief Financial Officer Analysts Charles Duncan - Piper Jaffray David Sherman - Li… read more...
Altimmune reports Q3 results
via: SeekingAlpha at 2017-11-09 16:25:29:000
Altimmune (NASDAQ: ALT ): Q3 EPS of -$2.05 Revenue of $4.59M (+410.0% Y/Y) Press Release More news on: Altimmune, Inc., Earnings news and commentary, Healthcare stocks news, , read more...
After Hours Gainers / Losers
via: SeekingAlpha at 2017-10-10 17:38:05:000
Top gainers, as of 5.25 p.m.: ALT +3.2% . CX +2.0% . MNKD +1.5% . ROKU +1.3% . SAVE +1.4% . More news on: Altimmune, Inc., Cemex, S.A.B. de C.V., MannKind Corporation, Stocks on the move, Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|---|---|---|---|---|---|---|---|
| 2017-02-06 | 2017-02-03 | 2017-01-24 | 2016-11-17 | 29.1 | SP | Dividend income |
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-05-05 | 10.0 | 1.0 | 10.0 |